Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis
Sponsor: Johns Hopkins University
Summary
This study evaluates the combined effect of botulinum toxin A (administered as Dysport® (Ipsen Pharmaceuticals)) and bracing in children with adolescent idiopathic scoliosis. Two thirds of patients will be treated with Dysport® and bracing, while the remaining patients will be treated with placebo and bracing.
Official title: Dysport ® (abobotulinumtoxinA) as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis
Key Details
Gender
All
Age Range
10 Years - 16 Years
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2020-09-03
Completion Date
2026-12-31
Last Updated
2025-12-09
Healthy Volunteers
No
Conditions
Interventions
AbobotulinumtoxinA
Paraspinal abobotulinumtoxinA injections (compared to placebo)
Placebos
Placebo prepared by Ipsen for use as control
Custom Thoracolumbosacral Orthosis
Non-operative external bracing for scoliosis curves
Locations (1)
Johns Hopkins University
Baltimore, Maryland, United States